Conformational states of human purine nucleoside phosphorylase at rest, at work, and with transition state analogues. 2010

Achelle A Edwards, and Jeremiah D Tipton, and Michael D Brenowitz, and Mark R Emmett, and Alan G Marshall, and Gary B Evans, and Peter C Tyler, and Vern L Schramm
Department of Biochemistry, Albert Einstein College of Medicine, Bronx, New York 10461, USA.

Human purine nucleoside phosphorylase (PNP) is a homotrimer binding tightly to the transition state analogues Immucillin-H (ImmH; K(d) = 56 pM) and DATMe-ImmH-Immucillin-H (DATMe-ImmH; K(d) = 8.6 pM). ImmH binds with a larger entropic penalty than DATMe-ImmH, a chemically more flexible inhibitor. The testable hypothesis is that PNP conformational states are more relaxed (dynamic) with DATMe-ImmH, despite tighter binding than with ImmH. PNP conformations are probed by peptide amide deuterium exchange (HDX) using liquid chromatography high-resolution Fourier transform ion cyclotron resonance mass spectrometry and by sedimentation rates. Catalytically equilibrating Michaelis complexes (PNP.PO(4).inosine <--> PNP.Hx.R-1-P) and inhibited complexes (PNP.PO(4).DATMe-ImmH and PNP.PO(4).ImmH) show protection from HDX at 9, 13, and 15 sites per subunit relative to resting PNP (PNP.PO(4)) in extended incubations. The PNP.PO(4).ImmH complex is more compact (by sedimentation rate) than the other complexes. HDX kinetic analysis of ligand-protected sites corresponds to peptides near the catalytic sites. HDX and sedimentation results establish that PNP protein conformation (dynamic motion) correlates more closely with entropy of binding than with affinity. Catalytically active turnover with saturated substrate sites causes less change in HDX and sedimentation rates than binding of transition state analogues. DATMe-ImmH more closely mimics the transition of human PNP than does ImmH and achieves strong binding interactions at the catalytic site while causing relatively modest alterations of the protein dynamic motion. Transition state analogues causing the most rigid, closed protein conformation are therefore not necessarily the most tightly bound. Close mimics of the transition state are hypothesized to retain enzymatic dynamic motions related to transition state formation.

UI MeSH Term Description Entries
D008969 Molecular Sequence Data Descriptions of specific amino acid, carbohydrate, or nucleotide sequences which have appeared in the published literature and/or are deposited in and maintained by databanks such as GENBANK, European Molecular Biology Laboratory (EMBL), National Biomedical Research Foundation (NBRF), or other sequence repositories. Sequence Data, Molecular,Molecular Sequencing Data,Data, Molecular Sequence,Data, Molecular Sequencing,Sequencing Data, Molecular
D010455 Peptides Members of the class of compounds composed of AMINO ACIDS joined together by peptide bonds between adjacent amino acids into linear, branched or cyclical structures. OLIGOPEPTIDES are composed of approximately 2-12 amino acids. Polypeptides are composed of approximately 13 or more amino acids. PROTEINS are considered to be larger versions of peptides that can form into complex structures such as ENZYMES and RECEPTORS. Peptide,Polypeptide,Polypeptides
D011485 Protein Binding The process in which substances, either endogenous or exogenous, bind to proteins, peptides, enzymes, protein precursors, or allied compounds. Specific protein-binding measures are often used as assays in diagnostic assessments. Plasma Protein Binding Capacity,Binding, Protein
D011487 Protein Conformation The characteristic 3-dimensional shape of a protein, including the secondary, supersecondary (motifs), tertiary (domains) and quaternary structure of the peptide chain. PROTEIN STRUCTURE, QUATERNARY describes the conformation assumed by multimeric proteins (aggregates of more than one polypeptide chain). Conformation, Protein,Conformations, Protein,Protein Conformations
D011683 Purine-Nucleoside Phosphorylase An enzyme that catalyzes the reaction between a purine nucleoside and orthophosphate to form a free purine plus ribose-5-phosphate. EC 2.4.2.1. Inosine Phosphorylase,Nicotinamide Riboside Phosphorylase,Purine Nucleoside Phosphorylases,Nucleoside Phosphorylases, Purine,Phosphorylase, Inosine,Phosphorylase, Nicotinamide Riboside,Phosphorylase, Purine-Nucleoside,Phosphorylases, Purine Nucleoside,Purine Nucleoside Phosphorylase,Riboside Phosphorylase, Nicotinamide
D011684 Purine Nucleosides Purines with a RIBOSE attached that can be phosphorylated to PURINE NUCLEOTIDES. Purine Nucleoside,Nucleoside, Purine,Nucleosides, Purine
D011744 Pyrimidinones Heterocyclic compounds known as 2-pyrimidones (or 2-hydroxypyrimidines) and 4-pyrimidones (or 4-hydroxypyrimidines) with the general formula C4H4N2O. Pyrimidinone,Pyrimidone,Pyrimidones
D002384 Catalysis The facilitation of a chemical reaction by material (catalyst) that is not consumed by the reaction. Catalyses
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000577 Amides Organic compounds containing the -CO-NH2 radical. Amides are derived from acids by replacement of -OH by -NH2 or from ammonia by the replacement of H by an acyl group. (From Grant & Hackh's Chemical Dictionary, 5th ed) Amide

Related Publications

Achelle A Edwards, and Jeremiah D Tipton, and Michael D Brenowitz, and Mark R Emmett, and Alan G Marshall, and Gary B Evans, and Peter C Tyler, and Vern L Schramm
December 2010, The journal of physical chemistry. B,
Achelle A Edwards, and Jeremiah D Tipton, and Michael D Brenowitz, and Mark R Emmett, and Alan G Marshall, and Gary B Evans, and Peter C Tyler, and Vern L Schramm
March 2010, Proceedings of the National Academy of Sciences of the United States of America,
Achelle A Edwards, and Jeremiah D Tipton, and Michael D Brenowitz, and Mark R Emmett, and Alan G Marshall, and Gary B Evans, and Peter C Tyler, and Vern L Schramm
November 2003, Journal of medicinal chemistry,
Achelle A Edwards, and Jeremiah D Tipton, and Michael D Brenowitz, and Mark R Emmett, and Alan G Marshall, and Gary B Evans, and Peter C Tyler, and Vern L Schramm
July 2003, Journal of medicinal chemistry,
Achelle A Edwards, and Jeremiah D Tipton, and Michael D Brenowitz, and Mark R Emmett, and Alan G Marshall, and Gary B Evans, and Peter C Tyler, and Vern L Schramm
June 2009, Biochemistry,
Achelle A Edwards, and Jeremiah D Tipton, and Michael D Brenowitz, and Mark R Emmett, and Alan G Marshall, and Gary B Evans, and Peter C Tyler, and Vern L Schramm
January 2007, Biochemistry,
Achelle A Edwards, and Jeremiah D Tipton, and Michael D Brenowitz, and Mark R Emmett, and Alan G Marshall, and Gary B Evans, and Peter C Tyler, and Vern L Schramm
January 2004, Postepy biochemii,
Achelle A Edwards, and Jeremiah D Tipton, and Michael D Brenowitz, and Mark R Emmett, and Alan G Marshall, and Gary B Evans, and Peter C Tyler, and Vern L Schramm
April 2011, Biochemistry,
Achelle A Edwards, and Jeremiah D Tipton, and Michael D Brenowitz, and Mark R Emmett, and Alan G Marshall, and Gary B Evans, and Peter C Tyler, and Vern L Schramm
May 2003, Biochemistry,
Achelle A Edwards, and Jeremiah D Tipton, and Michael D Brenowitz, and Mark R Emmett, and Alan G Marshall, and Gary B Evans, and Peter C Tyler, and Vern L Schramm
September 2009, Chemistry & biology,
Copied contents to your clipboard!